Why Hims & Hers Health (HIMS) Stock Fell 3.44% in 10 Minutes After Q3 Earnings on Nov 9, 2026
EPS of -$0.14 came in below the $0.08 estimate; revenue of $890.37 million came in below the $892.9 million estimate.
- HIMS fell 3.44% in the 10 minutes after the 16:05:02 ET headline, from $22.94 to $22.15.
- The 3.44% drop was larger than any reaction MoveSurge measured after Hims & Hers Health headlines between Aug 11, 2026 and Nov 8, 2026; the largest of those was +0.47% in 10 minutes, on Oct 21, 2026.
- 3.57 million shares changed hands in those 10 minutes.
16:05:02 ET
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +10m | +1m % | +10m % |
|---|---|---|---|---|---|---|
| HIMS | 22.94 | 22.94 | 21.85 | 22.15 | -4.75% | -3.44% |
Hims & Hers Health (HIMS) shares fell 3.44% in the 10 minutes after its Q3 results reached the MoveSurge news feed at 16:05:02 ET on Monday, November 9, 2026. EPS of -$0.14 came in below the $0.08 estimate; revenue of $890.37 million came in below the $892.9 million estimate.
HIMS in the first 10 minutes
The line that crossed at 16:05:02 ET: “HIMS Q3: revenue USD 890mln vs USD 892.9mln est”
From a reference price of $22.94 just before the headline, the stock was down 4.75% after one minute and down 3.44%, at $22.15, after 10 minutes. Part of the first-minute move came back by the 10-minute mark. 3.57 million shares changed hands in those 10 minutes. The headline crossed in after-hours trading, 5 minutes after the 4:00 ET close.
Hims & Hers Health Q3 results against estimates
| Measure | Reported | Estimate | Result |
|---|---|---|---|
| EPS | -$0.14 | $0.08 | Miss |
| Revenue | $890.37 million | $892.9 million | Miss |
Hims & Hers Health FY26 guidance
| Measure | New range | Prior range | Estimate | Change |
|---|---|---|---|---|
| Revenue | $3.13 billion to $3.15 billion | $3.1 billion to $3.3 billion | $3.21 billion | Lowered |
| Revenue | $875 million to $895 million | — | $953.45 million | — |
How HIMS traded after earlier earnings releases
| Report | EPS vs estimate | Revenue vs estimate | First move |
|---|---|---|---|
| Aug 10, 2026 | -$0.37 vs -$0.03 | $753.21 million vs $699.89 million | -2.62% in 15 min |
| May 11, 2026 | -$0.40 vs $0.04 | $608 million vs $617 million | not measured |
Earlier HIMS headlines and the measured reaction
The 3.44% drop was larger than any reaction MoveSurge measured after Hims & Hers Health headlines between Aug 11, 2026 and Nov 8, 2026; the largest of those was +0.47% in 10 minutes, on Oct 21, 2026.
- Oct 21, 2026, 08:21 ET: “Hims & Hers Health says its testosterone offering is scaling rapidly as of Q2 2026” (+0.47% in 10 minutes)
- Oct 20, 2026, 08:32 ET: “Hims & Hers Health launches Hims in Germany” (+0.32% in 10 minutes)
Hims & Hers Health at a glance
| Sector | Health Care |
| Industry | Medical/Nursing Services |
| Market value | $5.61 billion (as of Nov 9, 2026) |
Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.
How did Hims & Hers Health stock react to its Q3 earnings on November 9, 2026?
The stock fell 3.44% in the 10 minutes after its Q3 results crossed at 16:05:02 ET. EPS of -$0.14 came in below the $0.08 estimate; revenue of $890.37 million came in below the $892.9 million estimate.
How far did HIMS move after the headline?
From $22.94 just before the headline to $22.15 10 minutes later, a -3.44% move.
What did Hims & Hers Health guide for revenue?
Revenue guidance of $3.13 billion to $3.15 billion, replacing $3.1 billion to $3.3 billion; the estimate was $3.21 billion (lowered).
What else has moved HIMS stock recently?
The two largest measured reactions before November 9, 2026: Oct 21, 2026, Hims & Hers Health says its testosterone offering is scaling rapidly as of Q2 2026 (+0.47% in 10 minutes); Oct 20, 2026, Hims & Hers Health launches Hims in Germany (+0.32% in 10 minutes).
Sources
-
HIMS headline and measured reaction, Nov 9, 2026
— MoveSurge
The headline as it crossed, its timestamp, and the measured price reaction reported on this page.
Never miss the next market-moving story
Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.
Go live — 7 days for $29 Watch live headlines -- free